-
1
-
-
79952700279
-
Genetic and chemical models of colorectal cancer in mice
-
Nandan MO, Yang VW. Genetic and chemical models of colorectal cancer in mice. Curr Colorectal Cancer Rep. 2010;6:51-9.
-
(2010)
Curr Colorectal Cancer Rep
, vol.6
, pp. 51-59
-
-
Nandan, M.O.1
Yang, V.W.2
-
2
-
-
0037805547
-
RAS oncogenes: The first 30 years
-
DOI 10.1038/nrc1097
-
Malumbres M, Barbacid M. RAS oncogenes: the first 30 years. Nat Rev Cancer. 2003;3:459-65. (Pubitemid 37328850)
-
(2003)
Nature Reviews Cancer
, vol.3
, Issue.6
, pp. 459-465
-
-
Malumbres, M.1
Barbacid, M.2
-
3
-
-
0038311995
-
Ras family signaling: Therapeutic targeting
-
Cox AD, Der CJ. Ras family signaling: therapeutic targeting. Cancer Biol Ther. 2002;1:599-606.
-
(2002)
Cancer Biol Ther
, vol.1
, pp. 599-606
-
-
Cox, A.D.1
Der, C.J.2
-
4
-
-
22744445886
-
Signaling interplay in ras superfamily function
-
DOI 10.1016/j.cub.2005.07.010, PII S0960982205007487
-
Mitin N, Rossman KL, Der CJ. Signaling interplay in Ras superfamily function. Curr Biol. 2005;15:R563-74. (Pubitemid 41026614)
-
(2005)
Current Biology
, vol.15
, Issue.14
-
-
Mitin, N.1
Rossman, K.L.2
Der, C.J.3
-
6
-
-
50549218525
-
The limited in vitro lifetime of human diploid cell strains
-
Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res. 1965;37:614-36.
-
(1965)
Exp Cell Res
, vol.37
, pp. 614-636
-
-
Hayflick, L.1
-
7
-
-
0025279931
-
Telomeres shorten during ageing of human fibroblasts
-
Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature. 1990;345:458-60.
-
(1990)
Nature
, vol.345
, pp. 458-460
-
-
Harley, C.B.1
Futcher, A.B.2
Greider, C.W.3
-
9
-
-
0020521611
-
Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene
-
Newbold RF, Overell RW. Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene. Nature. 1983;304:648-51. (Pubitemid 13035507)
-
(1983)
Nature
, vol.304
, Issue.5927
, pp. 648-651
-
-
Newbold, R.F.1
Overell, R.W.2
-
10
-
-
0030944985
-
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16(INK4a)
-
DOI 10.1016/S0092-8674(00)81902-9
-
Serrano M, Lin AW, McCurrach ME, et al. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 1997;88:593-602. (Pubitemid 27152402)
-
(1997)
Cell
, vol.88
, Issue.5
, pp. 593-602
-
-
Serrano, M.1
Lin, A.W.2
McCurrach, M.E.3
Beach, D.4
Lowe, S.W.5
-
11
-
-
0032190629
-
Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling
-
Lin AW, Barradas M, Stone JC, et al. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev. 1998;12:3008-19. (Pubitemid 28469303)
-
(1998)
Genes and Development
, vol.12
, Issue.19
, pp. 3008-3019
-
-
Lin, A.W.1
Barradas, M.2
Stone, J.C.3
Van Aelst, L.4
Serrano, M.5
Lowe, S.W.6
-
12
-
-
0032192153
-
Senescence of human fibroblasts induced by oncogenic Raf
-
Zhu J, Woods D, McMahon M, et al. Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev. 1998;12:2997-3007. (Pubitemid 28469302)
-
(1998)
Genes and Development
, vol.12
, Issue.19
, pp. 2997-3007
-
-
Zhu, J.1
Woods, D.2
McMahon, M.3
Bishop, J.M.4
-
13
-
-
72949096792
-
Senescence in tumours: Evidence from mice and humans
-
Collado M, Serrano M. Senescence in tumours: evidence from mice and humans. Nat Rev Cancer. 2010;10:51-7.
-
(2010)
Nat Rev Cancer
, vol.10
, pp. 51-57
-
-
Collado, M.1
Serrano, M.2
-
14
-
-
34447543913
-
Cellular Senescence in Cancer and Aging
-
DOI 10.1016/j.cell.2007.07.003, PII S0092867407008902
-
Collado M, Blasco MA, Serrano M. Cellular senescence in cancer and aging. Cell. 2007;130:223-33. (Pubitemid 47081143)
-
(2007)
Cell
, vol.130
, Issue.2
, pp. 223-233
-
-
Collado, M.1
Blasco, M.A.2
Serrano, M.3
-
15
-
-
0023262990
-
Detection of high incidence of K-ras oncogenes during human colon tumorigenesis
-
DOI 10.1038/327298a0
-
Forrester K, Almoguera C, Han K, et al. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature. 1987;327:298-303. (Pubitemid 17075080)
-
(1987)
Nature
, vol.327
, Issue.6120
, pp. 298-303
-
-
Forrester, K.1
Almoguera, C.2
Han, K.3
-
16
-
-
0001446334
-
Morphologic responses to a murine erythroblastosis virus
-
Kirsten WH, Mayer LA. Morphologic responses to a murine erythroblastosis virus. J Natl Cancer Inst. 1967;39:311-35.
-
(1967)
J Natl Cancer Inst
, vol.39
, pp. 311-335
-
-
Kirsten, W.H.1
Mayer, L.A.2
-
19
-
-
0020677360
-
Characterization of a human colon/lung carcinoma oncogene
-
McCoy MS, Toole JJ, Cunningham JM, et al. Characterization of a human colon/lung carcinoma oncogene. Nature. 1983;302:79-81. (Pubitemid 13138483)
-
(1983)
Nature
, vol.302
, Issue.5903
, pp. 79-81
-
-
McCoy, M.S.1
Toole, J.J.2
Cunningham, J.M.3
-
20
-
-
0020578806
-
Structure and organization of the human Ki-ras proto-oncogene and a related processed pseudogene
-
McGrath JP, Capon DJ, Smith DH, et al. Structure and organization of the human Ki-ras proto-oncogene and a related processed pseudogene. Nature. 1983;304:501-6. (Pubitemid 13026945)
-
(1983)
Nature
, vol.304
, Issue.5926
, pp. 501-506
-
-
McGrath, J.P.1
Capon, D.J.2
Smith, D.H.3
-
21
-
-
33745265268
-
Germline missense mutations affecting KRAS isoform B are associated with a severe Noonan syndrome phenotype
-
DOI 10.1086/504394
-
Carta C, Pantaleoni F, Bocchinfuso G, et al. Germline missense mutations affecting KRAS Isoform B are associated with a severe Noonan syndrome phenotype. Am J Hum Genet. 2006;79: 129-35. (Pubitemid 43927383)
-
(2006)
American Journal of Human Genetics
, vol.79
, Issue.1
, pp. 129-135
-
-
Carta, C.1
Pantaleoni, F.2
Bocchinfuso, G.3
Stella, L.4
Vasta, I.5
Sarkozy, A.6
Digilio, C.7
Palleschi, A.8
Pizzuti, A.9
Grammatico, P.10
Zampino, G.11
Dallapiccola, B.12
Gelb, B.D.13
Tartaglia, M.14
-
22
-
-
0030829782
-
K-Ras is essential for the development of the mouse embryo
-
Koera K, Nakamura K, Nakao K, et al. K-ras is essential for the development of the mouse embryo. Oncogene. 1997;15:1151-9. (Pubitemid 27429618)
-
(1997)
Oncogene
, vol.15
, Issue.10
, pp. 1151-1159
-
-
Koera, K.1
Nakamura, K.2
Nakao, K.3
Miyoshi, J.4
Toyoshima, K.5
Hatta, T.6
Otani, H.7
Aiba, A.8
Katsuki, M.9
-
23
-
-
0035136213
-
Targeted genomic disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and development
-
DOI 10.1128/MCB.21.5.1444-1452.2001
-
Esteban LM, Vicario-Abejon C, Fernandez-Salguero P, et al. Targeted genomic disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and development. Mol Cell Biol. 2001;21: 1444-52. (Pubitemid 32156364)
-
(2001)
Molecular and Cellular Biology
, vol.21
, Issue.5
, pp. 1444-1452
-
-
Esteban, L.M.1
Vicario-Abejon, C.2
Fernandez-Salguero, P.3
Fernandez-Medarde, A.4
Swaminathan, N.5
Yienger, K.6
Lopez, E.7
Malumbres, M.8
McKay, R.9
Ward, J.M.10
Pellicer, A.11
Santos, E.12
-
24
-
-
0019960812
-
A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene
-
DOI 10.1038/300149a0
-
Reddy EP, Reynolds RK, Santos E, et al. A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature. 1982;300: 149-52. (Pubitemid 12006347)
-
(1982)
Nature
, vol.300
, Issue.5888
, pp. 149-152
-
-
Reddy, E.P.1
Reynolds, R.K.2
Santos, E.3
Barbacid, M.4
-
25
-
-
0020404981
-
Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change
-
DOI 10.1038/300762a0
-
Taparowsky E, Suard Y, Fasano O, et al. Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change. Nature. 1982;300:762-5. (Pubitemid 13224357)
-
(1982)
Nature
, vol.300
, Issue.5894
, pp. 762-765
-
-
Taparowsky, E.1
Suard, Y.2
Fasano, O.3
-
26
-
-
0020546075
-
Acquisition of transforming properties by alternative point mutations within c-bas/has human proto-oncogene
-
Yuasa Y, Srivastava SK, Dunn CY, et al. Acquisition of transforming properties by alternative point mutations within c-bas/has human proto-oncogene. Nature. 1983;303:775-9. (Pubitemid 13054490)
-
(1983)
Nature
, vol.303
, Issue.5920
, pp. 775-779
-
-
Yuasa, Y.1
Srivastava, S.K.2
Dunn, C.Y.3
-
27
-
-
0021289343
-
Somatic activation of ras(K) gene in a human ovarian carcinoma
-
Feig LA, Bast Jr RC, Knapp RC, et al. Somatic activation of rasK gene in a human ovarian carcinoma. Science. 1984;223:698-701. (Pubitemid 14186804)
-
(1984)
Science
, vol.223
, Issue.4637
, pp. 698-701
-
-
Feig, L.A.1
Bast Jr., R.C.2
Knapp, R.C.3
Cooper, G.M.4
-
29
-
-
1642622866
-
A method to detect and characterize point mutations in transcribed genes: Amplification and overexpression of the mutant cKi-ras allele in human tumor cells
-
DOI 10.1073/pnas.82.22.7575
-
Winter E, Yamamoto F, Almoguera C, et al. A method to detect and characterize point mutations in transcribed genes: amplification and overexpression of the mutant c-Ki-ras allele in human tumor cells. Proc Natl Acad Sci USA. 1985;82:7575-9. (Pubitemid 16204390)
-
(1985)
Proceedings of the National Academy of Sciences of the United States of America
, vol.82
, Issue.22
, pp. 7575-7579
-
-
Winter, E.1
Yamamoto, F.2
Almoguera, C.3
Perucho, M.4
-
30
-
-
0023251288
-
A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome
-
DOI 10.1038/327430a0
-
Hirai H, Kobayashi Y, Mano H, et al. A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome. Nature. 1987;327:430-2. (Pubitemid 17075817)
-
(1987)
Nature
, vol.327
, Issue.6121
, pp. 430-432
-
-
Hirai, H.1
Kobayashi, Y.2
Mano, H.3
-
31
-
-
33644622238
-
Germline KRAS mutations cause Noonan syndrome
-
Schubbert S, Zenker M, Rowe SL, et al. Germline KRAS mutations cause Noonan syndrome. Nat Genet. 2006;38:331-6.
-
(2006)
Nat Genet
, vol.38
, pp. 331-336
-
-
Schubbert, S.1
Zenker, M.2
Rowe, S.L.3
-
32
-
-
0036739336
-
Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype
-
Bazan V, Migliavacca M, Zanna I, et al. Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype. Ann Oncol. 2002;13:1438-46.
-
(2002)
Ann Oncol
, vol.13
, pp. 1438-1446
-
-
Bazan, V.1
Migliavacca, M.2
Zanna, I.3
-
33
-
-
64049090889
-
Clinical relevance of EGFR- and KRAS-status in colorectal cancer patients treated with monoclonal antibodies directed against the EGFR
-
Heinemann V, Stintzing S, Kirchner T, et al. Clinical relevance of EGFR- and KRAS-status in colorectal cancer patients treated with monoclonal antibodies directed against the EGFR. Cancer Treat Rev. 2009;35:262-71.
-
(2009)
Cancer Treat Rev
, vol.35
, pp. 262-271
-
-
Heinemann, V.1
Stintzing, S.2
Kirchner, T.3
-
35
-
-
42649145667
-
Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer
-
Amado RG, Wolf M, Peeters M, et al. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. J Clin Oncol. 2008;26:1626-34.
-
(2008)
J Clin Oncol
, vol.26
, pp. 1626-1634
-
-
Amado, R.G.1
Wolf, M.2
Peeters, M.3
-
36
-
-
77449101632
-
Activating KRAS mutations and overexpression of epidermal growth factor receptor as independent predictors in metastatic colorectal cancer patients treated with cetuximab
-
Yen LC, Uen YH, Wu DC, et al. Activating KRAS mutations and overexpression of epidermal growth factor receptor as independent predictors in metastatic colorectal cancer patients treated with cetuximab. Ann Surg. 2010;251:254-60.
-
(2010)
Ann Surg
, vol.251
, pp. 254-260
-
-
Yen, L.C.1
Uen, Y.H.2
Wu, D.C.3
-
37
-
-
80051794463
-
Molecular prognostic and predictive markers in colorectal cancer: Current status
-
in press
-
Lee JK, Chan AT. Molecular prognostic and predictive markers in colorectal cancer: current status. Curr Colorectal Cancer Rep. 2011, in press
-
(2011)
Curr Colorectal Cancer Rep
-
-
Lee, J.K.1
Chan, A.T.2
-
38
-
-
0027439205
-
Production of transgenic mice expressing the Ki-ras oncogene under the control of a thyroglobulin promoter
-
Santelli G, de Franciscis V, Portella G, et al. Production of transgenic mice expressing the Ki-ras oncogene under the control of a thyroglobulin promoter. Cancer Res. 1993;53:5523-7. (Pubitemid 23342178)
-
(1993)
Cancer Research
, vol.53
, Issue.22
, pp. 5523-5527
-
-
Santelli, G.1
De Franciscis, V.2
Portella, G.3
Chiappetta, G.4
D'Alessio, A.5
Califano, D.6
Rosati, R.7
Mineo, A.8
Monaco, C.9
Manzo, G.10
Pozzi, L.11
Vecchio, G.12
-
39
-
-
0028277921
-
Expression of wild-type and mutant simian virus 40 large tumor antigens in villus-associated enterocytes of transgenic mice
-
DOI 10.1073/pnas.91.15.6914
-
Kim SH, Roth KA, Coopersmith CM, et al. Expression of wildtype and mutant simian virus 40 large tumor antigens in villus associated enterocytes of transgenic mice. Proc Natl Acad Sci USA. 1994;91:6914-8. (Pubitemid 24226772)
-
(1994)
Proceedings of the National Academy of Sciences of the United States of America
, vol.91
, Issue.15
, pp. 6914-6918
-
-
Kim, S.H.1
Roth, K.A.2
Coopersmith, C.M.3
Pipas, J.M.4
Gordon, J.I.5
-
40
-
-
0035953550
-
Somatic activation of the K-ras oncogene causes early onset lung cancer in mice
-
DOI 10.1038/35074129
-
Johnson L, Mercer K, Greenbaum D, et al. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature. 2001;410:1111-6. (Pubitemid 32391044)
-
(2001)
Nature
, vol.410
, Issue.6832
, pp. 1111-1116
-
-
Johnson, L.1
Mercer, K.2
Greenbaum, D.3
Bronson, R.T.4
Crowley, D.5
Tuveson, D.A.6
Jacks, T.7
-
41
-
-
0026638820
-
Targeted oncogene activation by site-specific recombination in transgenic mice
-
Lakso M, Sauer B, Mosinger Jr B, et al. Targeted oncogene activation by site-specific recombination in transgenic mice. Proc Natl Acad Sci USA. 1992;89:6232-6.
-
(1992)
Proc Natl Acad Sci USA
, vol.89
, pp. 6232-6236
-
-
Lakso, M.1
Sauer, B.2
Mosinger Jr., B.3
-
42
-
-
0033621427
-
Inducible gene knockouts in the small intestinal and colonic epithelium
-
DOI 10.1074/jbc.274.53.38071
-
Saam JR, Gordon JI. Inducible gene knockouts in the small intestinal and colonic epithelium. J Biol Chem. 1999;274:38071-82. (Pubitemid 30026877)
-
(1999)
Journal of Biological Chemistry
, vol.274
, Issue.53
, pp. 38071-38082
-
-
Saam, J.R.1
Gordon, J.I.2
-
43
-
-
0033525861
-
Regulatory sequences of the mouse villin gene that efficiently drive transgenic expression in immature and differentiated epithelial cells of small and large intestines
-
DOI 10.1074/jbc.274.10.6476
-
Pinto D, Robine S, Jaisser F, et al. Regulatory sequences of the mouse villin gene that efficiently drive transgenic expression in immature and differentiated epithelial cells of small and large intestines. J Biol Chem. 1999;274:6476-82. (Pubitemid 29111063)
-
(1999)
Journal of Biological Chemistry
, vol.274
, Issue.10
, pp. 6476-6482
-
-
Pinto, D.1
Robine, S.2
Jaisser, F.3
El Marjou, F.4
Louvard, D.5
-
44
-
-
0037031856
-
Cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine
-
DOI 10.1074/jbc.M204935200
-
Madison BB, Dunbar L, Qiao XT, et al. Cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine. J Biol Chem. 2002;277:33275-83. (Pubitemid 34984848)
-
(2002)
Journal of Biological Chemistry
, vol.277
, Issue.36
, pp. 33275-33283
-
-
Madison, B.B.1
Dunbar, L.2
Qiao, X.T.3
Braunstein, K.4
Braunstein, E.5
Gumucio, D.L.6
-
45
-
-
2142709556
-
Inducible Cre-Mediated Control of Gene Expression in the Murine Gastrointestinal Tract: Effect of Loss of β-Catenin
-
DOI 10.1053/j.gastro.2004.03.020
-
Ireland H, Kemp R, Houghton C, et al. Inducible Cre-mediated control of gene expression in the murine gastrointestinal tract: effect of loss of beta-catenin. Gastroenterology. 2004;126:1236-46. (Pubitemid 38552788)
-
(2004)
Gastroenterology
, vol.126
, Issue.5
, pp. 1236-1246
-
-
Ireland, H.1
Kemp, R.2
Houghton, C.3
Howard, L.4
Clarke, A.R.5
Sansom, O.J.6
Winton, D.J.7
-
46
-
-
4043059169
-
Tissue-specific and inducible Cre-mediated recombination in the gut epithelium
-
DOI 10.1002/gene.20042
-
el Marjou F, Janssen KP, Chang BH, et al. Tissue-specific and inducible Cre-mediated recombination in the gut epithelium. Genesis. 2004;39:186-93. (Pubitemid 39079517)
-
(2004)
Genesis
, vol.39
, Issue.3
, pp. 186-193
-
-
El Marjou, F.1
Janssen, K.-P.2
Chang, B.H.-J.3
Li, M.4
Hindie, V.5
Chan, L.6
Louvard, D.7
Chambon, P.8
Metzger, D.9
Robine, S.10
-
47
-
-
0036328995
-
Targeted expression of oncogenic K-ras in intestinal epithelium causes spontaneous tumorigenesis in mice
-
DOI 10.1053/gast.2002.34786
-
Janssen KP, el-Marjou F, Pinto D, et al. Targeted expression of oncogenic K-ras in intestinal epithelium causes spontaneous tumorigenesis in mice. Gastroenterology. 2002;123:492-504. (Pubitemid 34827194)
-
(2002)
Gastroenterology
, vol.123
, Issue.2
, pp. 492-504
-
-
Janssen, K.1
Marjou, F.E.2
Pinto, D.3
Sastre, X.4
Rouillard, D.5
Fouquet, C.6
Soussi, T.7
Louvard, D.8
Robine, S.9
-
48
-
-
0035893252
-
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
-
DOI 10.1101/gad.943001
-
Jackson EL, Willis N, Mercer K, et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 2001;15:3243-8. (Pubitemid 34008190)
-
(2001)
Genes and Development
, vol.15
, Issue.24
, pp. 3243-3248
-
-
Jackson, E.L.1
Willis, N.2
Mercer, K.3
Bronson, R.T.4
Crowley, D.5
Montoya, R.6
Jacks, T.7
Tuveson, D.A.8
-
49
-
-
11144356354
-
G12D stimulates proliferation and widespread neoplastic and developmental defects
-
DOI 10.1016/S1535-6108(04)00085-6, PII S1535610804000856
-
Tuveson DA, Shaw AT, Willis NA, et al. Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell. 2004;5:375-87. (Pubitemid 38482073)
-
(2004)
Cancer Cell
, vol.5
, Issue.4
, pp. 375-387
-
-
Tuveson, D.A.1
Shaw, A.T.2
Willis, N.A.3
Silver, D.P.4
Jackson, E.L.5
Chang, S.6
Mercer, K.L.7
Grochow, R.8
Hock, H.9
Crowley, D.10
Hingorani, S.R.11
Zaks, T.12
King, C.13
Jacobetz, M.A.14
Wang, L.15
Bronson, R.T.16
Orkin, S.H.17
DePinho, R.A.18
Jacks, T.19
-
50
-
-
42549127895
-
Oncogenic K-ras promotes early carcinogenesis in the mouse proximal colon
-
DOI 10.1002/ijc.23383
-
Calcagno SR, Li S, Colon M, et al. Oncogenic K-ras promotes early carcinogenesis in the mouse proximal colon. Int J Cancer. 2008;122:2462-70. (Pubitemid 351590478)
-
(2008)
International Journal of Cancer
, vol.122
, Issue.11
, pp. 2462-2470
-
-
Calcagno, S.R.1
Li, S.2
Colon, M.3
Kreinest, P.A.4
Thompson, E.A.5
Fields, A.P.6
Murray, N.R.7
-
51
-
-
33748988989
-
Loss of Apc allows phenotypic manifestation of the transforming properties of an endogenous K-ras oncogene in vivo
-
DOI 10.1073/pnas.0604130103
-
Sansom OJ, Meniel V, Wilkins JA, et al. Loss of Apc allows phenotypic manifestation of the transforming properties of an endogenous K-ras oncogene in vivo. Proc Natl Acad Sci USA. 2006;103:14122-7. (Pubitemid 44452990)
-
(2006)
Proceedings of the National Academy of Sciences of the United States of America
, vol.103
, Issue.38
, pp. 14122-14127
-
-
Sansom, O.J.1
Meniel, V.2
Wilkins, J.A.3
Cole, A.M.4
Oien, K.A.5
Marsh, V.6
Jamieson, T.J.7
Guerra, C.8
Ashton, G.H.9
Barbacid, M.10
Clarke, A.R.11
-
52
-
-
0031041171
-
Differential regulation of Raf-1, A-Raf, and B-Raf by oncogenic Ras and tyrosine kinases
-
DOI 10.1074/jbc.272.7.4378
-
Marais R, Light Y, Paterson HF, et al. Differential regulation of Raf-1, A-Raf, and B-Raf by oncogenic ras and tyrosine kinases. J Biol Chem. 1997;272:4378-83. (Pubitemid 27078513)
-
(1997)
Journal of Biological Chemistry
, vol.272
, Issue.7
, pp. 4378-4383
-
-
Marais, R.1
Light, Y.2
Paterson, H.F.3
Mason, C.S.4
Marshall, C.J.5
-
53
-
-
18444374405
-
Mutations of the BRAF gene in human cancer
-
DOI 10.1038/nature00766
-
Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949-54. (Pubitemid 34716871)
-
(2002)
Nature
, vol.417
, Issue.6892
, pp. 949-954
-
-
Davies, H.1
Bignell, G.R.2
Cox, C.3
Stephens, P.4
Edkins, S.5
Clegg, S.6
Teague, J.7
Woffendin, H.8
Garnett, M.J.9
Bottomley, W.10
Davis, N.11
Dicks, E.12
Ewing, R.13
Floyd, Y.14
Gray, K.15
Hall, S.16
Hawes, R.17
Hughes, J.18
Kosmidou, V.19
Menzies, A.20
Mould, C.21
Parker, A.22
Stevens, C.23
Watt, S.24
Hooper, S.25
Wilson, R.26
Jayatilake, H.27
Gusterson, B.A.28
Cooper, C.29
Shipley, J.30
Hargrave, D.31
Pritchard-Jones, K.32
Maitland, N.33
Chenevix-Trench, G.34
Riggins, G.J.35
Bigner, D.D.36
Palmleri, G.37
Cossu, A.38
Flanagan, A.39
Nicholson, A.40
Ho, J.W.C.41
Leung, S.Y.42
Yuen, S.T.43
Weber, B.L.44
Seigler, H.F.45
Darrow, T.L.46
Paterson, H.47
Marais, R.48
Marshall, C.J.49
Wooster, R.50
Stratton, M.R.51
Futreal, P.A.52
more..
-
54
-
-
0037194728
-
RAF/RAS oncogenes and mismatch-repair status
-
DOI 10.1038/418934a
-
Rajagopalan H, Bardelli A, Lengauer C, et al. Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature. 2002;418:934. (Pubitemid 34976022)
-
(2002)
Nature
, vol.418
, Issue.6901
, pp. 934
-
-
Rajagopalan, H.1
Bardelli, A.2
Lengauer, C.3
Kinzler, K.W.4
Vogelstein, B.5
Velculescu, V.E.6
-
55
-
-
33746565515
-
Role of Raf Kinase in Cancer: Therapeutic Potential of Targeting the Raf/MEK/ERK Signal Transduction Pathway
-
DOI 10.1053/j.seminoncol.2006.04.002, PII S009377540600176X
-
Gollob JA, Wilhelm S, Carter C, et al. Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway. Semin Oncol. 2006;33:392-406. (Pubitemid 44142735)
-
(2006)
Seminars in Oncology
, vol.33
, Issue.4
, pp. 392-406
-
-
Gollob, J.A.1
Wilhelm, S.2
Carter, C.3
Kelley, S.L.4
-
56
-
-
34248591612
-
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
-
DOI 10.1038/sj.onc.1210422, PII 1210422
-
Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogenactivated protein kinase cascade for the treatment of cancer. Oncogene. 2007;26:3291-310. (Pubitemid 46763022)
-
(2007)
Oncogene
, vol.26
, Issue.22
, pp. 3291-3310
-
-
Roberts, P.J.1
Der, C.J.2
-
57
-
-
12144289677
-
Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF
-
DOI 10.1016/S0092-8674(04)00215-6, PII S0092867404002156
-
Wan PT, Garnett MJ, Roe SM, et al. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B RAF. Cell. 2004;116:855-67. (Pubitemid 38410730)
-
(2004)
Cell
, vol.116
, Issue.6
, pp. 855-867
-
-
Wan, P.T.C.1
Garnett, M.J.2
Roe, S.M.3
Lee, S.4
Niculescu-Duvaz, D.5
Good, V.M.6
Project, C.G.7
Jones, C.M.8
Marshall, C.J.9
Springer, C.J.10
Barford, D.11
Marais, R.12
-
58
-
-
60949110722
-
Modelling oncogenic Ras/Raf signalling in the mouse
-
Karreth FA, Tuveson DA. Modelling oncogenic Ras/Raf signalling in the mouse. Curr Opin Genet Dev. 2009;19:4-11.
-
(2009)
Curr Opin Genet Dev
, vol.19
, pp. 4-11
-
-
Karreth, F.A.1
Tuveson, D.A.2
-
59
-
-
29244487538
-
V600EB-raf induces proliferation and developmental defects in mice and transformation of primary fibroblasts
-
DOI 10.1158/0008-5472.CAN-05-2211
-
Mercer K, Giblett S, Green S, et al. Expression of endogenous oncogenic V600EB-raf induces proliferation and developmental defects in mice and transformation of primary fibroblasts. Cancer Res. 2005;65:11493-500. (Pubitemid 41821707)
-
(2005)
Cancer Research
, vol.65
, Issue.24
, pp. 11493-11500
-
-
Mercer, K.1
Giblett, S.2
Green, S.3
Lloyd, D.4
Dias, S.D.5
Plumb, M.6
Marais, R.7
Pritchard, C.8
-
60
-
-
33847201454
-
A new mouse model to explore the initiation, progression, and therapy of BRAFV600Einduced lung tumors
-
Dankort D, Filenova E, Collado M, et al. A new mouse model to explore the initiation, progression, and therapy of BRAFV600Einduced lung tumors. Genes Dev. 2007;21:379-84.
-
(2007)
Genes Dev
, vol.21
, pp. 379-384
-
-
Dankort, D.1
Filenova, E.2
Collado, M.3
-
61
-
-
78449292368
-
BRAF inactivation drives aneuploidy by deregulating CRAF
-
Kamata T, Hussain J, Giblett S, et al. BRAF inactivation drives aneuploidy by deregulating CRAF. Cancer Res. 2010;70:8475-86.
-
(2010)
Cancer Res
, vol.70
, pp. 8475-8486
-
-
Kamata, T.1
Hussain, J.2
Giblett, S.3
-
62
-
-
52049116971
-
CRAF autophosphorylation of serine 621 is required to prevent its proteasome-mediated degradation
-
Noble C, Mercer K, Hussain J, et al. CRAF autophosphorylation of serine 621 is required to prevent its proteasome-mediated degradation. Mol Cell. 2008;31:862-72.
-
(2008)
Mol Cell
, vol.31
, pp. 862-872
-
-
Noble, C.1
Mercer, K.2
Hussain, J.3
-
63
-
-
29144462587
-
Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization
-
DOI 10.1016/j.molcel.2005.10.022, PII S109727650501717X
-
Garnett MJ, Rana S, Paterson H, et al. Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization. Mol Cell. 2005;20:963-9. (Pubitemid 41814884)
-
(2005)
Molecular Cell
, vol.20
, Issue.6
, pp. 963-969
-
-
Garnett, M.J.1
Rana, S.2
Paterson, H.3
Barford, D.4
Marais, R.5
-
64
-
-
74849109743
-
Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF
-
Heidorn SJ, Milagre C, Whittaker S, et al. Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF. Cell. 2010;140:209-21.
-
(2010)
Cell
, vol.140
, pp. 209-221
-
-
Heidorn, S.J.1
Milagre, C.2
Whittaker, S.3
-
65
-
-
77949732073
-
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wildtype BRAF
-
Poulikakos PI, Zhang C, Bollag G, et al. RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wildtype BRAF. Nature. 2010;464:427-30.
-
(2010)
Nature
, vol.464
, pp. 427-430
-
-
Poulikakos, P.I.1
Zhang, C.2
Bollag, G.3
|